Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jarolim, P.
Right arrow Articles by Cohen, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jarolim, P.
Right arrow Articles by Cohen, C. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Band 3 Tuscaloosa: Pro327----Arg327 substitution in the cytoplasmic domain of erythrocyte band 3 protein associated with spherocytic hemolytic anemia and partial deficiency of protein 4.2

P Jarolim, J Palek, HL Rubin, JT Prchal, C Korsgren and CM Cohen

Department of Biomedical Research, St. Elizabeth's Hospital of Boston, Tufts University School of Medicine, MA 02135.

Protein 4.2 is a major red blood cell (RBC) protein that interacts with the band 3 protein and with ankyrin. Inherited deficiencies of this protein are associated with spherocytic hemolytic anemia, but the molecular basis of this defect is unknown. We have studied the underlying defect in a patient with spherocytic hemolytic anemia whose RBCs had a partial (29% +/- 5%) deficiency of protein 4.2. We have first studied the binding of normal ankyrin and protein 4.2 to patient inside-out vesicles (IOVs) stripped of peripheral proteins. While the binding of ankyrin was normal, the predicted maximal binding capacity of patient IOVs for band 4.2 was 20% to 33% lower than that of control IOVs, suggesting a defect in the cytoplasmic domain of band 3 (cdb3). An additional line of evidence pointing to a possible abnormality of band 3 was an abnormal proteolytic digest of cdb3. To elucidate the underlying molecular defect, we have cloned and sequenced the cDNA coding for cdb3 from the patient. One band 3 allele was found to be normal, while clones corresponding to the other allele contained two mutations: substitution A----G in nucleotide 166, changing codon 56 from AAG to GAG (Lys----Glu), and substitution C----G in nucleotide 980, changing codon 327 from CCC to CGC (Pro----Arg). Since the Lys56--- -Glu56 substitution is found in a common asymptomatic variant of the band 3 protein designated band 3 Memphis, we conclude that either the Pro327----Arg327 substitution itself, or in combination with the band 3 Memphis polymorphism, underlies the abnormal binding of protein 4.2 to cdb3 and results in the spherocytic phenotype.

Volume 80, Issue 2, pp. 523-529, 07/15/1992
Copyright © 1992 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
A. M. Toye, S. Ghosh, M. T. Young, G. K. Jones, R. B. Sessions, M. Ramauge, P. Leclerc, J. Basu, J. Delaunay, and M. J. A. Tanner
Protein-4.2 association with band 3 (AE1, SLCA4) in Xenopus oocytes: effects of three natural protein-4.2 mutations associated with hemolytic anemia
Blood, May 15, 2005; 105(10): 4088 - 4095.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Zhang, A. Kiyatkin, J. T. Bolin, and P. S. Low
Crystallographic structure and functional interpretation of the cytoplasmic domain of erythrocyte membrane band 3
Blood, November 1, 2000; 96(9): 2925 - 2933.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Jarolim, H.L. Rubin, D. Zakova, J. Storry, and M.E. Reid
Characterization of Seven Low Incidence Blood Group Antigens Carried by Erythrocyte Band 3 Protein
Blood, December 15, 1998; 92(12): 4836 - 4843.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. R.M. Lima, J. A.R. Gontijo, J. B. Lopes de Faria, F. F. Costa, and S. T.O. Saad
Band 3 Campinas: A Novel Splicing Mutation in the Band 3 Gene (AE1 ) Associated With Hereditary Spherocytosis, Hyperactivity of Na+/Li+ Countertransport and an Abnormal Renal Bicarbonate Handling
Blood, October 1, 1997; 90(7): 2810 - 2818.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Hassoun, J.N. Vassiliadis, J. Murray, P.R. Njolstad, J. J. Rogus, S.K. Ballas, F. Schaffer, P. Jarolim, V. Brabec, and J. Palek
Characterization of the Underlying Molecular Defect in Hereditary Spherocytosis Associated With Spectrin Deficiency
Blood, July 1, 1997; 90(1): 398 - 406.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Alloisio, P. Texier, A. Vallier, M.L. Ribeiro, L. Morle, M. Bozon, E. Bursaux, P. Maillet, P. Goncalves, M.J.A. Tanner, et al.
Modulation of Clinical Expression and Band 3 Deficiency in Hereditary Spherocytosis
Blood, July 1, 1997; 90(1): 414 - 420.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Zhou and P. S. Low
Characterization of the Reversible Conformational Equilibrium in the Cytoplasmic Domain of Human Erythrocyte Membrane Band 3
J. Biol. Chem., October 5, 2001; 276(41): 38147 - 38151.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1992 by American Society of Hematology         Online ISSN: 1528-0020